Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
EHAB 
Enhabit Inc. (EHAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/26/2025: EHAB (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.75
1 Year Target Price $9.75
| 1 | Strong Buy |
| 0 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.61% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/26/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 475.48M USD | Price to earnings Ratio - | 1Y Target Price 9.75 |
Price to earnings Ratio - | 1Y Target Price 9.75 | ||
Volume (30-day avg) 5 | Beta 1.29 | 52 Weeks Range 6.47 - 10.90 | Updated Date 12/27/2025 |
52 Weeks Range 6.47 - 10.90 | Updated Date 12/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -1.14% | Operating Margin (TTM) 6.37% |
Management Effectiveness
Return on Assets (TTM) 3.06% | Return on Equity (TTM) -1.69% |
Valuation
Trailing PE - | Forward PE 17.99 | Enterprise Value 934294363 | Price to Sales(TTM) 0.45 |
Enterprise Value 934294363 | Price to Sales(TTM) 0.45 | ||
Enterprise Value to Revenue 0.89 | Enterprise Value to EBITDA 17.7 | Shares Outstanding 50607075 | Shares Floating 39770582 |
Shares Outstanding 50607075 | Shares Floating 39770582 | ||
Percent Insiders 3.41 | Percent Institutions 104.29 |
Upturn AI SWOT
Enhabit Inc.
Company Overview
History and Background
Enhabit Inc. was formed as a spin-off from Encompass Health Corporation. The separation was completed on July 1, 2022, creating two independent, publicly traded companies. Enhabit Inc. inherited the home health and hospice business from Encompass Health, focusing on providing comprehensive post-acute care services in patients' homes.
Core Business Areas
- Home Health Services: Providing skilled nursing, physical therapy, occupational therapy, speech therapy, and home health aide services to patients in their homes. These services aim to help patients recover from illness, injury, or surgery, manage chronic conditions, and maintain independence.
- Hospice Services: Offering palliative care and support to patients with life-limiting illnesses. This includes pain and symptom management, emotional and spiritual support for patients and their families, and bereavement services.
Leadership and Structure
Enhabit Inc. is led by a management team with extensive experience in the healthcare industry. The organizational structure is designed to support its decentralized service delivery model, with local teams managing patient care and operations, overseen by regional and corporate leadership. Key leadership roles include Chief Executive Officer, Chief Financial Officer, and heads of operations for home health and hospice segments.
Top Products and Market Share
Key Offerings
- Home Health Care: Comprehensive in-home care services including skilled nursing, therapy, and aide support. Market share data is not publicly disclosed for individual service lines but the company is a significant player in the home health market. Competitors include LHC Group (now part of Optum), Kindred at Home (now part of Centerbridge Partners), and numerous smaller regional providers.
- Hospice Care: Palliative and supportive care for terminally ill patients, including pain management, emotional support, and family assistance. Similar to home health, specific market share for hospice is not detailed, but Enhabit operates a substantial network. Competitors include Kindred Hospice, Amedisys (now part of Optum), and many other hospice providers.
Market Dynamics
Industry Overview
The home health and hospice industry is characterized by a growing demand driven by an aging population, a preference for aging in place, and a shift towards value-based care models that favor home-based interventions. The industry is fragmented with a mix of large national providers and smaller local agencies. Regulatory changes and reimbursement policies from Medicare and Medicaid significantly impact profitability and operational strategies.
Positioning
Enhabit Inc. is positioned as a leading provider of post-acute care services, leveraging its extensive network of care centers and experienced clinical staff. Its competitive advantages include a broad geographic reach, established referral relationships with hospitals and physicians, and a commitment to quality care. The spin-off from Encompass Health aimed to allow Enhabit to focus exclusively on its core home health and hospice operations and pursue its own growth strategies.
Total Addressable Market (TAM)
The US home health and hospice market is substantial and projected to grow. Estimates vary, but the TAM is in the tens of billions of dollars annually, driven by demographic trends and healthcare policy. Enhabit Inc. aims to capture a significant portion of this market by expanding its service offerings, geographic footprint, and by optimizing operational efficiencies to deliver high-quality, cost-effective care.
Upturn SWOT Analysis
Strengths
- Extensive network of care centers across numerous states.
- Experienced clinical staff and established care protocols.
- Strong brand recognition inherited from Encompass Health.
- Focus on post-acute care, a growing segment of healthcare.
- Established relationships with referral sources (hospitals, physicians).
Weaknesses
- Reliance on Medicare and Medicaid reimbursement, which are subject to change.
- Integration challenges post-spin-off could impact operational efficiency.
- Potential for increased competition from larger, integrated healthcare systems.
- Labor shortages in healthcare can impact staffing levels and quality of care.
Opportunities
- Expanding into new geographic markets through organic growth and acquisitions.
- Leveraging technology to improve patient care coordination and operational efficiency.
- Developing specialized care programs (e.g., for specific chronic conditions).
- Increasing demand for palliative and end-of-life care services.
- Partnerships with accountable care organizations (ACOs) and health systems.
Threats
- Changes in government reimbursement policies and regulatory environment.
- Intensifying competition from national providers and emerging players.
- Increased scrutiny on quality of care and patient outcomes.
- Cybersecurity risks and data privacy concerns.
- Economic downturns affecting healthcare spending.
Competitors and Market Share
Key Competitors
- LHC Group (now part of Optum) (LHCG - delisted)
- Kindred at Home (private)
- Amedisys (AMED)
- HCRS (private)
- Sunrise Medical (private)
Competitive Landscape
Enhabit Inc. operates in a competitive landscape where differentiation is achieved through quality of care, breadth of services, geographic reach, and efficient operations. Its advantages lie in its scale and established infrastructure, while potential disadvantages could include pricing pressures, labor availability, and the need to adapt to evolving regulatory requirements more agilely than larger, more bureaucratic organizations.
Major Acquisitions
Not Applicable (as a recent spin-off)
- Year:
- Acquisition Price (USD millions):
- Strategic Rationale: N/A
Growth Trajectory and Initiatives
Historical Growth: Prior to its spin-off, the home health and hospice business of Encompass Health experienced growth driven by market demand and strategic initiatives. Post-spin-off, Enhabit's growth trajectory will be shaped by its independent strategy, including potential acquisitions, expansion into new markets, and optimization of its existing operations.
Future Projections: Future growth projections for Enhabit Inc. will be influenced by industry trends, regulatory changes, competitive pressures, and the company's ability to execute its strategic plans. Analyst reports and company guidance, when available, will provide insights into expected revenue and earnings growth.
Recent Initiatives: Since its spin-off, Enhabit's initiatives would likely focus on establishing its independent corporate identity, optimizing its operational structure, strengthening its market position, and potentially pursuing strategic partnerships or acquisitions to accelerate growth.
Summary
Enhabit Inc. is a significant player in the growing home health and hospice market, benefiting from an aging population and a preference for in-home care. Its strengths include a wide operational footprint and experienced staff. However, the company faces challenges from regulatory changes, reimbursement pressures, and labor shortages. Successful execution of its independent growth strategy, focusing on operational efficiency and potentially strategic acquisitions, will be crucial for its long-term success. Monitoring its financial health and market positioning relative to competitors will be key.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (e.g., 10-K, 10-Q)
- Industry Reports
- Financial News Outlets
- Company Investor Relations
Disclaimers:
This analysis is based on publicly available information and aims to provide a structured overview. It is not financial advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. Market share data is estimated where precise figures are not available. Competitor status (public/private) can change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Enhabit Inc.
Exchange NYSE | Headquaters Dallas, TX, United States | ||
IPO Launch date 2022-07-01 | President, CEO & Director Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 10700 | Website https://www.ehab.com |
Full time employees 10700 | Website https://www.ehab.com | ||
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.